To ask the Secretary of State for Health and Social Care, with reference to the Answer of 17 December 2014 to Question 218002 on monthly payments from MFET Ltd to people who contracted HIV through NHS treatment and the Answer of 7 January 2014 to Question 181908 on monthly payments through the Skipton Fund State 2 to people who contracted hepatitis C through NHS treatment, what estimate his Department has made of the average length of time for monthly payments to be made from the England Infected Blood Support Scheme to people affected by NHS contaminated blood products.
The Government established the England Infected Blood Support Scheme (EIBSS) in 2017 to provide dedicated ex-gratia financial and non-financial support to people infected by HIV and/or hepatitis C through treatment with National Health Service-supplied blood or blood products, and their affected families. This scheme is currently administered by the NHS Business Services Authority.
EIBSS provides tiered non-discretionary annual payments to eligible infected beneficiaries, based on their type and stage of infection (hepatitis C and/or HIV). The majority of beneficiaries opt for these payments to be split into monthly instalments.
EIBSS aims to process new applications within 30 working days of receipt. Eligible beneficiaries’ payments are then transferred within 10 days after their application has been approved. These payments are backdated to the month that the beneficiary’s application was initially received by EIBSS.
The Department hold EIBSS to account via monthly review meetings. EIBSS is required to maintain a key performance indicator of 90% around the time frame for processing new applications, which it has met.